Trial Profile
An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study between the Altana formulation of pantoprazole delayed-release granules and the Wyeth formulation of pantoprazole delayed-release granules in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Mar 2007
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastrointestinal disorders
- Focus Pharmacokinetics
- Sponsors Wyeth
- 21 Mar 2007 New trial record.